Identification, Synthesis, and Evaluation of New Neuraminidase Inhibitors
摘要:
High-throughput screening was performed on similar to 6800 compounds to identify KR-72039 as an inhibitor of H1N1 and H5N1 neuraminidases (NAs). Structureactivity relationship studies led to 3e, which inhibited H5N1 NA with an IC50 of 2.8 mu M and blocked viral replication. Docking analysis shows that compounds bind to loop-430 around the NA active site. Compound 3l additionally inhibited H7N9 NA, making it a dual inhibitor of N1- and N2-type NAs.
The present invention provides compositions and methods for inhibiting PTPN22 for restoring human central B-cell tolerance or for treating or preventing an autoimmune disease or disorder.
本发明提供了抑制 PTPN22 的组合物和方法,用于恢复人类中枢 B 细胞耐受性或治疗或预防自身免疫性疾病或紊乱。
COMPOSITIONS AND METHODS FOR INHIBITING PTPN22
申请人:YALE UNIVERSITY
公开号:US20200316070A1
公开(公告)日:2020-10-08
The present invention provides compositions and methods for inhibiting PTPN22 for restoring human central B-cell tolerance or for treating or preventing an autoimmune disease or disorder.